Product image of Ibuprofen Gen.Orph (Ibuprofen) supplied by GNH India

Ibuprofen Gen.Orph

Active Ingredient:
Ibuprofen
Origin:
EU

Ibuprofen Gen.Orph (Ibuprofen)

Ibuprofen, the active ingredient in Ibuprofen Gen.Orph, is a nonsteroidal anti-inflammatory drug presented as an intravenous solution for intravenous use. It provides analgesic, antipyretic, and anti‑inflammatory effects for adults experiencing acute pain, fever, or inflammatory conditions.

GNH India supplies Ibuprofen Gen.Orph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and distributes the product to healthcare facilities across multiple continents.

Manufacturer / TM Owner

Gen.Orph

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ibuprofen administered intravenously acts on the cyclooxygenase pathway to relieve pain, reduce inflammation, and lower fever.

  • Pain: Provides rapid analgesia in acute postoperative or trauma‑related pain.
  • Inflammation: Decreases inflammatory response in musculoskeletal or postoperative swelling.
  • Fever: Lowers elevated body temperature in febrile patients.

How It Works

  • Ibuprofen inhibits both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, blocking the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin synthesis diminishes peripheral sensitization of nociceptors, lowers the hypothalamic set‑point for temperature, and curtails inflammatory mediators, resulting in analgesic, antipyretic, and anti‑inflammatory effects.

Side Effects

Intravenous ibuprofen may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: transient feeling of sickness.
  • Headache: mild to moderate intensity.
  • Injection site pain: discomfort at the infusion site.

Serious or Rare Side Effects

  • Gastrointestinal bleeding: potentially life‑threatening hemorrhage.
  • Severe allergic reaction (anaphylaxis): rapid onset of airway compromise.
  • Renal impairment: reduced kidney function, especially in at‑risk patients.

Precautions & Warnings

Prior to initiating therapy, clinicians should evaluate patient‑specific risk factors and follow safe handling practices.

  • Assess renal function: evaluate baseline creatinine before initiating therapy.
  • Monitor gastrointestinal risk: avoid in patients with active ulcers or bleeding.
  • Check cardiovascular status: use cautiously in patients with history of thrombotic disease.
  • Avoid use in late pregnancy: category D indicates potential fetal risk.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Ibuprofen can interact with several drug classes, requiring careful assessment of benefit versus risk.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.
  • High‑dose aspirin: potentiates renal and gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may reduce renal function.
  • Diuretics: risk of electrolyte imbalance.
  • Lithium: ibuprofen can increase lithium levels, necessitating serum monitoring.

Frequently Asked Questions

Ibuprofen Gen.Orph is an intravenous formulation of ibuprofen used to provide rapid relief of moderate to severe pain, to reduce inflammation in acute surgical or traumatic settings, and to lower fever in hospitalized patients. It is typically prescribed when a fast‑acting, controllable anti‑inflammatory effect is required.

Ibuprofen works by inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for the synthesis of prostaglandins. By reducing prostaglandin production, it diminishes peripheral pain signaling, lowers the hypothalamic set‑point for body temperature, and curtails the inflammatory cascade.

The dose of Ibuprofen Gen.Orph is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal or hepatic function. Dosage regimens are individualized and should follow the prescriber’s instructions and local hospital protocols.

Ibuprofen Gen.Orph is classified as pregnancy category D, indicating evidence of risk to the fetus, especially in the third trimester. It is generally avoided during pregnancy and should be used only if the potential benefit justifies the risk. Limited data are available for breastfeeding, and caution is advised.

To order Ibuprofen Gen.Orph, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Intravenous ibuprofen delivers the drug directly into the bloodstream, achieving faster plasma concentrations and more predictable analgesia compared with oral formulations, which require gastrointestinal absorption. Compared with other IV NSAIDs, ibuprofen offers a well‑characterized safety profile and is often chosen for its cost‑effectiveness and broad therapeutic window.

Ibuprofen Gen.Orph should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. The product should be kept in its original packaging until use, and any unused portion should be discarded according to local regulations.

Ibuprofen Gen.Orph is administered by intravenous infusion, typically diluted in a compatible IV fluid and infused over a period of 15‑30 minutes, depending on the clinical protocol. Administration should be performed by qualified healthcare personnel under aseptic conditions.

The most serious risks include gastrointestinal bleeding, severe allergic reactions such as anaphylaxis, and acute renal impairment, especially in patients with pre‑existing kidney disease or volume depletion. Monitoring for signs of bleeding, renal function changes, and hypersensitivity is essential during therapy.

Ibuprofen Gen.Orph is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, and in the third trimester of pregnancy. Caution is also advised for patients with compromised renal or hepatic function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibuprofen

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT